Cepheid's Multi-Target Test Design Enables Detection of Influenza Variants

SUNNYVALE, Calif., Dec. 8, 2022 /PRNewswire/ -- Currently circulating mutant strains of influenza highlight the need for multi-target diagnostic tests. Two recently identified mutations in the

Related Keywords

United States ,United Kingdom ,Darwa Peterson ,Mike Loeffelholz ,David Persing ,Scientific Affairs ,Cepheid ,Healthcare Products Regulatory Agency ,Our Scientific Affairs ,Human Influenza ,Chief Scientific Officer ,Gene Target ,Senior Director ,Matrix Gene Causing ,Negative Result ,Commercial Molecular ,Vitro Diagnostic Medical ,Emergency Use Authorization ,Cepheid Media Inquiries ,Ulti ,Target ,Pest ,Design ,Nables ,Detection ,Influenza ,Variants ,